Ludwig Center at MSK
Ludwig Institute for Cancer Research
United States of America
I am a surgical oncologist and member of the Breast Cancer Management team at MSKCC. I conduct research focused on understanding how breast cancers decrease potentially beneficial anti-tumor immune responses. I became interested in immune responses during a three-year research fellowship at MSKCC where I studied the immune system in the setting of inflammation and infection.
Cancer surgery, breast cancer, cancer therapies
Plitas, George, et al. "Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis." Journal of Experimental Medicine 205.6 (2008): 1277-1283.
Brandl, Katharina, et al. "MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection." Journal of Experimental Medicine 204.8 (2007): 1891-1900.
Brandl, Katharina, et al. "Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits." Nature 455.7214 (2008): 804.